Neuropsychiatric symptom phenotypes for early detection of risk in older adults
Open Access
- 11 November 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (11) , e70869
Abstract
INTRODUCTION: We examined whether early neuropsychiatric symptom (NPS) patterns were associated with cognitive and neuropathologic changes. METHODS: Latent class analysis within 20,599 cognitively unimpaired older adults in the National Alzheimer's Coordinating Center dataset identified NPS phenotypes. Progression to cognitive impairment, cognitive trajectories, and neuropathology across phenotypes were assessed. RESULTS: Four NPS phenotypes were identified: (1) Low‐All, (2) High‐Depression, (3) High‐Agitation/Anxiety/Irritability (hAAI), and (4) High‐All. Risk of progression to mild cognitive impairment (MCI)/dementia differed across phenotypes (Low‐All < High‐Depression < hAAI < High‐All, p < 0.001). High‐All and hAAI showed the lowest baseline performance and lower practice effects on cognitive tests, while High‐Depression had persistently lower attention scores. The hAAI group had greater amyloid and neuritic plaque burden and higher arteriosclerosis severity compared to other groups ( p < 0.01) DISCUSSION: Higher global NPS, and those with high agitation, anxiety, and irritability, showed greater odds of cognitive decline than depressive symptoms alone, underscoring the potential prognostic utility of early NPS patterns in predicting cognitive decline. Highlights: Identified four, data‐driven neuropsychiatric symptoms (NPS) phenotypes in cognitively unimpaired older adults NPS phenotypes were differentially linked to progression, cognition, and pathology High‐all and high‐anxiety, agitation, and irritability had poorer baseline cognition NPS phenotypes may serve as early indicators of neurodegenerative disease riskKeywords
Funding Information
- Alzheimer's Association (AARG‐22‐723000)
This publication has 54 references indexed in Scilit:
- RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy‐Related Pathology in the Dementia PatientBrain Pathology, 2008
- Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistryActa Neuropathologica, 2006
- Alzheimer Disease With Amygdala Lewy BodiesJournal of Neuropathology & Experimental Neurology, 2006
- Neuropsychiatric Symptoms and Quality of Life in Alzheimer DiseaseThe American Journal of Geriatric Psychiatry, 2005
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentJournal of Internal Medicine, 2004
- Sequence of Aβ-Protein Deposition in the Human Medial Temporal LobeJournal of Neuropathology & Experimental Neurology, 2000
- Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric InventoryThe Journal of Neuropsychiatry and Clinical Neurosciences, 2000
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984